Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy
Crossref DOI link: https://doi.org/10.1007/s00520-016-3388-7
Published Online: 2016-08-24
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chasen, Martin
Urban, Laszlo
Schnadig, Ian
Rapoport, Bernardo
Powers, Dan
Arora, Sujata
Navari, Rudolph
Schwartzberg, Lee
Gridelli, Cesare
License valid from 2016-08-24